RNA aptamers targeting the carboxyl terminus of KRAS oncoprotein generated by an improved SELEX with isothermal RNA amplification

Oligonucleotides

Volumn 17, Issue 1, 2007, Pages 12-21

  Tanaka, Yoichiro ^a,b   Akagi, Kiwamu ^a   Nakamura, Yoshikazu ^b,c   Kozu, Tomoko ^a  

^a SAITAMA CANCER CENTER   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; APTAMER; K RAS PROTEIN; MUTANT PROTEIN; RNA;

AMINO ACID SEQUENCE; ARTICLE; BINDING AFFINITY; BIOTINYLATION; CARBOXY TERMINAL SEQUENCE; CHEMICAL REACTION; COMBINATORIAL CHEMISTRY; FARNESYLATION; GENE AMPLIFICATION; GENE MUTATION; IN VITRO STUDY; ISOLATION PROCEDURE; MALIGNANT TRANSFORMATION; ONCOGENE K RAS; PRIORITY JOURNAL; PROTEIN TARGETING; SCINTILLATION;

APTAMERS, NUCLEOTIDE; BASE SEQUENCE; CONSENSUS SEQUENCE; HUMANS; MUTATION; NUCLEIC ACID AMPLIFICATION TECHNIQUES; PROTO-ONCOGENE PROTEINS; RAS PROTEINS; RNA; SELEX APTAMER TECHNIQUE; TEMPERATURE;

EID: 34247465512     PISSN: 15454576     EISSN: None     Source Type: Journal    
DOI: 10.1089/oli.2006.0035R1     Document Type: Article

References (28)

1. APOLLONI, A., PRIOR, I.A., LINDSAY, M., PARTON, R.G., and HANCOCK, J.F. (2000). H-ras but not K-ras traffics to the plasma membrane through the exocytic pathway. Mol. Cell Biol. 20, 2475-2487.
2. CAPON, D.J., SEEBURG, P.H., MCGRATH, J.P., HAYFLICK, J.S., EDMAN, U., LEVINSON, A.D., and GOEDDEL, D.V. (1983). Activation of Ki-ras2 gene in human colon and lung carcinomas by two different point mutations. Nature 304, 507-513.
3. CHATAWAY, T.K., and BARRITT, G.J. (1995). Purification of histidine-tagged ras and its use in the detection of ras binding proteins. Mol. Cell. Biochem. 144, 167-173.
4. COMPTON, J. (1991). Nucleic acid sequence-based amplification. Nature 350, 91-92.
5. DATSON, N.A., DUYK, G.M., VAN OMMEN, J.B., and DEN DUNNEN, J.T. (1994). Specific isolation of 3′-terminal exons of human genes by exon trapping. Nucleic Acids Res. 22, 4148-4153.
6. DOWNWARD, J. (2003). Targeting RAS signalling pathways in cancer therapy. Nature Rev. Cancer 3, 11-22.
7. DUURSMA, A.M., and AGAMI, R. (2003). Ras interference as cancer therapy. Semin. Cancer Biol. 13, 267-273.
8. ELLINGTON, A.D., and SZOSTAK, J.W. (1990). In vitro selection of RNA molecules that bind specific ligands. Nature 346, 818-822.
9. GILBERT, B.A., SHA, M., WATHEN, S.T., and RANDO, R.R. (1997). RNA aptamers that specifically bind to a K Ras-derived farnesylated peptide. Bioorg. Med. Chem. 5, 1115-1122.
10. GUATELLI, J.C., WHITFIELD, K.M., KWOH, D.Y., BARRINGER, K.J., RICHMAN, D.D., and GINGERAS, T.R. (1990). Isothermal, in vitro amplification of nucleic acids by a multienzyme reaction modeled after retroviral replication. Proc. Natl. Acad. Sci. USA 87:1874-1878.
11. HANCOCK, J.F. (2003). Ras proteins: different signals from different locations. Nature Rev. Mol. Cell. Biol. 4, 373-384.
12. HANCOCK, J.F., PATERSON, H., and MARSHALL, C.J. (1990). A polybasic domain or palmitoylation is required in addition to the CAAX motif to localize p21ras to the plasma membrane. Cell 63, 133-139.
13. HART, H.E., and GREENWALD, E.B. (1979). Scintillation-proximity assay of antigen-antibody binding kinetics: concise communication. J. Nucl. Med. 20, 1062-1065.
14. JACKSON, J.H., LI, J.W., BUSS, J.E., DER, C.J., and COCHRANE, C.G. (1994). Polylysine domain of K-ras 4B protein is crucial for malignant transformation. Proc. Natl. Acad. Sci. USA 91, 12730-12734.
15. JONAS, V., ALDEN, M.J., CURRY, J.I., KAMISANGO, K., KNOTT, C.A., LANKFORD, R., WOLFE, J.M., and MOORE, D.F. (1993). Detection and identification of Mycobacterium tuberculosis directly from sputum sediments by amplification of rRNA. J. Clin. Microbiol. 31, 2410-2416.
16. KIJIMA, H., YAMAZAKI, H., NAKAMURA, M., SCANLON, K.J., OSAMURA, R.Y., and UEYAMA, Y. (2004). Ribozyme against mutant K-ras mRNA suppresses tumor growth of pancreatic cancer. Int. J. Oncol. 24, 559-564.
17. KLOOG, Y., and COX, A.D. (2000). RAS inhibitors: potential for cancer therapeutics. Mol. Med. Today. 6, 398-402.
18. LOWE, P.N., PAGE, M.J., BRADLEY, S., RHODES, S., SYDENHAM, M., PATERSON, H., and SKINNER, R.H. (1991). Characterization of recombinant human Kirsten-ras (4B) p21 produced at high levels in Escherichia coli and insect baculovirus expression systems. J. Biol. Chem. 266, 1672-1678.
19. MALEK, L., SOOKNANAN, R., and COMPTON, J. (1994). Nucleic acid sequence-based amplification (NASBA). Methods Mol. Biol. 28, 253-260.
20. MALUMBRES, M., and BARBACID, M. (2003). RAS oncogenes: the first 30 years. Nature Rev. Cancer 3, 459-465.
21. MEDER, D., and SIMONS, K. (2005). Cell biology. Ras on the roundabout. Science 307, 1731-1733.
22. MILLER, A.F., PAPASTAVROS, M.Z., and REDFIELD, A.G. (1992). NMR studies of the conformational change in human N-p21ras produced by replacement of bound GDP with the GTP analog GTP gamma S. Biochemistry 31, 10208-10216.
23. OEHLENSCHLAGER, F., SCHWILLE, P., and EIGEN, M. (1996). Detection of HIV-1 RNA by nucleic acid sequence-based amplification combined with fluorescence correlation spectroscopy. Proc. Natl. Acad. Sci. USA 93, 12811-12816.
24. OGURO, A., OHTSU, T., SVITKTN, Y.V., SONENBERG, N., and NAKAMURA, Y. (2003). RNA aptamers to initiation factor 4A helicase hinder cap-dependent translation by blocking ATP hydrolysis. 9, 394-407.
25. PASTERNACK, R., VUORINEN, P., and MIETTINEN, A. (1997). Evaluation of the Gen-Probe Chlamydia trachomatis transcription-mediated amplification assay with urine specimens from women. J. Clin. Microbiol. 35, 676-678.
26. REUTHER, G.W., and DER, C.J. (2000). The Ras branch of small GTPases: Ras family members don't fall far from the tree. Curr. Opin. Cell Biol. 12, 157-165.
27. TUERK, C., and GOLD, L. (1990). Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 249, 505-510.
28. WU, Z., DEMMA, M., STRICKLAND, C.L., SYTO, R., LE, H.V., WINDSOR, W.T., and WEBER, P.C. (1999). High-level expression, purification, kinetic characterization and crystallization of protein farnesyltransferase beta-subunit C-terminal mutants. Protein Eng. 12, 341-348.